Merck, Ridgeback Announce Trial Results For Antiviral Medication

Watch VideoA potential breakthrough in treating COVID-19: Merck and Ridgeback Biotherapeutics announced its oral antiviral medicine significantly reduced the risk of hospitalization and death in a trial. 

Merck said it plans to seek emergency use authorization from the FDA as soon as possible for its pill. If it moves...